Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients

Summary

This is a study to investigate the clinical efficacy and safety of epoetin beta 36,000 IU compared with placebo when administrated subcutaneously (s.c.) once-weekly for 12 weeks to anemic patients with lung cancer or gynecologic cancer undergoing chemotherapy.

Timeline

Start

2008-05

Primary completion

2009-05

Completion

2009-09

Drugs

Indications